Connor, Clark & Lunn Investment Management Ltd. Cardiovascular Systems Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$12.74 - $15.12 $178,296 - $211,604	13,995 Added 19.01%	87,600 $1.19 Million
Q3 2022 Nov 10, 2022	BUY	$12.93 - $17.17 $561,640 - $745,813	43,437 Added 143.98%	73,605 $1.02 Million
Q2 2022 Aug 05, 2022	BUY	$13.53 - $23.34 $284,319 - $490,466	21,014 Added 229.56%	30,168 $433,000
Q1 2022 May 12, 2022	BUY	$16.14 - $22.6 $147,745 - $206,880	9,154 New	9,154 $207,000
Q4 2018 Feb 12, 2019	SELL	$25.26 - $38.43 $586,663 - $892,536	-23,225 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$33.27 - $39.25 $772,695 - $911,581	23,225 New	23,225 $909,000
Q3 2017 Nov 14, 2017	SELL	$27.25 - $31.55 $907,070 - $1.05 Million	-33,287 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	33,287	33,287 $1.07 Million

Others Institutions Holding CSII

# of Institutions

Shares Held

35.5K

Call Options Held

Put Options Held

View Full List

About Cardiovascular Systems Inc

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

More about CSII

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account